1 No-Brainer Dividend Index Fund to Buy Right Now for Less Than $500 -- and Another Dividend Fund Yielding 11%

You can invest in individual dividend-paying stocks, but opting for a dividend-focused ETF makes it easier.
The Schwab U.S. Dividend Equity ETF has a solid track record and a respectable yield.
The relatively new, and actively managed, JPMorgan Equity Premium Income ETF has performed well.
10 stocks we like better than Schwab U.S. Dividend Equity ETF ›
Two of the best things in the investment world are index funds and dividend-paying stocks. So an even better thing, arguably, would be a dividend-focused index fund. Here's a look at a well-regarded index exchange-traded fund (ETF) that recently boasted a yield of 4%. (ETFs are funds that trade like stocks, making it easy to get in and out of them.)
I'll also offer for your consideration a more aggressive income-oriented ETF that recently sported a dividend yield of 11%. Check them out and see whether either or both would be a good fit for your portfolio. You can invest in either with less than $500 -- or with more.
Dividend-paying stocks used to be thought of by many people as mainly suitable for grandparents -- but that's increasingly not the case as more investors wake up to their appeal. Consider these eye-opening numbers.
Dividend-Paying Status
Average Annual Total Return, 1973-2024
Dividend growers and initiators
10.24%
Dividend payers
9.20%
No change in dividend policy
6.75%
Dividend non-payers
4.31%
Dividend shrinkers and eliminators
(0.89%)
Equal-weighted S&P 500 index
7.65%
Data source: Ned Davis Research and Hartford Funds.
You can, of course, study the universe of stocks and carefully choose promising dividend-paying stocks for your portfolio. But you might instead make it easy on yourself by just investing in a good fund that does that work for you.
The Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) is a compelling pick for multiple reasons. Let's start with its expense ratio (annual fee), which is just 0.06%. That means you'll only pay $6 a year for every $10,000 you have invested in the fund.
The ETF tracks the Dow Jones U.S. Dividend 100 Index -- which encompasses 100 stocks with track records of paying dividends for at least 10 years and which also appear financially healthy. That last part, based on factors such as cash flow to total debt and return on equity, is important, because companies that aren't financially healthy may at some point need to reduce their dividends.
Here's how the fund has performed in the past.
Period
Average annual gain
Past 3 years
4.58%
Past 5 years
12.76%
Past 10 years
10.47%
Since inception (Oct. 20, 2011)
12.19%
Source: SchwabAssetManagement.com, as of May 8, 2025.
Pretty good, right? Note, though, that the next five or 10 years might feature lower (or higher) returns. The S&P 500 has averaged annual total returns of close to 10% (ignoring inflation) over long periods, and the past few years have featured higher-than-average returns.
Another thing to like about the fund is its relatively hefty dividend yield, recently 4%. Plunk $10,000 into this ETF and you can expect somewhere around $400 in dividends over the course of the next year. As the companies in the Dow Jones U.S. Dividend 100 Index grow over time, many of them will be increasing their dividends, so you can generally expect to collect more in dividend income from year to year.
So what's in this ETF? Here are its top 10 holdings as of May 8.
Stock
Weight in ETF
Recent yield
Coca-Cola
4.47%
2.8%
Verizon Communications
4.43%
6.2%
Altria Group
4.42%
6.7%
ConocoPhillips
4.27%
3.6%
Lockheed Martin
4.25%
2.8%
Home Depot
4.06%
2.5%
Cisco Systems
4.03%
2.8%
Chevron
3.89%
5.0%
AbbVie
3.84%
3.5%
Amgen
3.77%
3.5%
Source: SchwabAssetManagement.com and Morningstar.com. Figures as of May 8, 2025.
These 10 holdings together make up about 41% of the ETF's value. About 20% of its assets are in consumer defensive stocks, 19% in energy stocks, and nearly 15% in healthcare stocks.
If you're looking for much more income from your investments, you might want to take a look at the JPMorgan Equity Premium Income ETF (NYSEMKT: JEPI). It's fairly new, with an inception date of May 20, 2020, and it has drawn a lot of interest with its dividend yield, recently 7.8% (on a 12-month rolling basis).
As you might be starting to suspect, the JPMorgan Equity Premium Income ETF is not a standard dividend ETF. It claims to be the world's largest actively managed ETF (as opposed to being an index fund, or index ETF), and here's how it describes itself:
Designed to provide current income while maintaining prospects for capital appreciation.
Generates income through a combination of selling options and investing in U.S. large cap stocks, seeking to deliver a monthly income stream from associated option premiums and stock dividends.
Seeks to deliver a significant portion of the returns associated with the S&P 500 Index with less volatility, in addition to monthly income.
So what's its strategy? Well, it holds lots of stocks (recently around 113) chosen by its managers. On top of that, it uses equity-linked notes and covered calls (a kind of option) to add to its performance.
Take a closer look at this ETF if it interests you. Understand that its performance can vary along with the economic environment. Its expense ratio is 0.35%, costing you $35 annually per $10,000 invested in the fund.
Whether you take the more straightforward route of investing for dividend income or you park some money in the JPMorgan ETF, be sure that you are saving and investing for retirement.
Before you buy stock in Schwab U.S. Dividend Equity ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Schwab U.S. Dividend Equity ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $598,613!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $753,878!*
Now, it's worth noting Stock Advisor's total average return is 922% — a market-crushing outperformance compared to 169% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of May 12, 2025
Selena Maranjian has positions in AbbVie, Altria Group, Amgen, Schwab U.S. Dividend Equity ETF, and Verizon Communications. The Motley Fool has positions in and recommends AbbVie, Amgen, Chevron, Cisco Systems, and Home Depot. The Motley Fool recommends Lockheed Martin and Verizon Communications. The Motley Fool has a disclosure policy.
1 No-Brainer Dividend Index Fund to Buy Right Now for Less Than $500 -- and Another Dividend Fund Yielding 11% was originally published by The Motley Fool

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Hill

26 minutes ago

• The Hill

Oil rises and US stock futures slip as markets react to US strike on Iran nuclear sites

NEW YORK (AP) — The price of oil rose and U.S. stock futures fell as global markets react to the U.S. strike against nuclear targets in Iran. The price of Brent crude oil, the international standard, rose 2.6% to $79 a barrel. U.S. crude rose 2.6% to $75.76 a barrel. On Saturday, U.S. forces attacked three Iranian nuclear and military sites, further increasing the stakes in the war between Israel and Iran. Futures for the S&P 500 and the Dow Jones Industrial Average slipped 0.3%, while Nasdaq futures fell 0.5%. Treasury yields were little changed. The modest moves indicate markets are taking the latest development in stride. The conflict, which began with an Israeli attack against Iran on June 13, has sent oil prices yo-yoing, which has in turn caused see-saw moves for the U.S. stock market, because of rising and ebbing fears that the war could disrupt the global flow of crude. Iran is a major producer of oil and also sits on the narrow Strait of Hormuz, through which much of the world's crude passes. An Iran retaliation that included closing off the waterway would be technically difficult to pull off but traders are afraid Iran could severely disrupt transit through it, sending insurance rates spiking and making shippers nervous to move without U.S. Navy escorts Some analysts think Iran is unlikely to close down the waterway because the country uses it to transport its own crude, mostly to China, and oil is a major source of revenue for the regime. 'It's a scorched earth possibility, a Sherman-burning-Atlanta move,' said Tom Kloza, chief market analyst at Turner Mason & Co. 'It's not probable.' Kloza thinks oil futures will ease back down after initial fears blow over. Ed Yardeni, a long-time analyst, agreed, writing in a report that Tehran leaders would likely hold back. 'They aren't crazy,' he wrote in a note to investors Sunday. 'The price of oil should fall and stock markets around the world should climb higher.' Other experts aren't so sure. Andy Lipow, a Houston analyst covering oil markets for 45 years, said countries are not always rational actors and that he wouldn't be surprised if Tehran lashed out for political or emotional reasons. 'If the Strait of Hormuz was completely shut down, oil prices would rise to $120 to $130 a barrel,' said Lipow, predicting that that would translate to about $4.50 a gallon at the pump and hurt consumers in other ways. 'It would mean higher prices for all those goods transported by truck, and it would be more difficult for the Fed to lower interest rates.'

Business Insider

26 minutes ago

• Business Insider

Short Report: Short interest in residential solar heats up again

Welcome to this week's installment of 'The Short Interest Report' – The Fly's weekly recap of short interest trends among some of the most widely followed high-short-float stocks. Using the data from our partner which utilizes the latest information from stock lenders to estimate short interest changes for thousands of publicly traded companies, this report will screen for some of biggest changes in short interest as a percentage of free float and days-to-cover ratios while also considering the short interest data on some of the more volatile and heavier-traded names of the week. Based on the availability of data from Ortex, the report tracks the trading period that covers prior Friday through Thursday of this week, excluding holidays. As a basis of comparison for stocks discussed below, the S&P 500 index was down 1.1%, the Nasdaq Composite was down 0.6%, the Russell 2000 index was down 1.3%, the Russell 2000 Growth ETF (IWO) was down 1.2%, and the Russell 2000 Value ETF (IWN) was up 0.5% in the four-day trading session range through June 18. Confident Investing Starts Here: SHORT INTEREST GAINERS Ortex-reported short interest on Sunrun (RUN) jumped from 27% to over 30% with days-to-cover on the name up from 3.2 to 3.9 this week. Similarly, short positioning as a percentage of free float on SolarEdge (SEDG) went up from 30.5% to 32.6%. Bearish appetite for both names had been receding as short-sellers took profits following meaningful declines in their respective stock prices on May 22, when House Republicans' passed budget bill was seen as containing a worse than feared scenario of cuts to renewable incentives for solar/wind energy and both stocks subsequently erased their losses over the first half of June. With the Senate budget bill out this week also proposing a full phase-out of solar and wind energy tax credit as soon as 2028, bears are renewing their bets on more Washington-imposed pain and residential solar names are back in freefall. Shares of Sunrun were down 27.6% and those of SolarEdge fell 19.2% in the four-day period covered through Thursday. Year-to-date, Sunrun is off by 33%, though SolarEdge is still up 21%. Ortex-reported short interest on Designer Brands (DBI) had retreated from a five-month high of 32% to 27% last week as bears took profits from a 35% plunge in shares following the company's disappointing Q1 results and pulled guidance on June 10. With no signs of a bounce and multiple sell-side price target cuts, however, bears are now rebuilding their positions. Shorts as a percentage of free float were up four percentage points this week to 30.8, days-to-cover rose to 5.9 from 5.0, and the stock was down 5.4% in the four-day period covered. Year-to-date, Designer Brands is now down 57%. Ortex-reported short interest on Guess (GES) had fallen to a 14-month low level just under 20% in the first week of June and ahead of its Q1 earnings on June 5. While the stock bounced despite the company's below-consensus Q2 guide and FY26 outlook cut, bears are returning to the name. This week, shorts as a percentage of free float on Guess were up from 20.2% to 22.7% – a three-week high. Likewise, days-to-cover on Guess jumped from 6.4 to 9.3 – a three-month high – even though volumes held relatively steady. The stock was down 4% in the four-session period through Wednesday, though Friday's 5% rally erased all of those losses. Year-to-date, Guess is still down about 15%. Ortex-reported short interest on Centrus Energy (LEU) had fallen to the lowest level since November of 2024 in the first week of June at about 17% as the stock had nearly quadrupled over the prior four-month period from April lows. This week however, shorts as a percentage of free float were up from 18.7% to 20.6%, with bears questioning whether the extreme bounce in the nuclear fuel component supplier is sustainable or deserves a pause. Indeed, while the stock is up 14% in the four-day period covered, Friday saw the upside momentum stall out after an intraday jump of 16% to finish up a more modest 5%. Year-to-date, shares of Centrus are still up a whopping 185%. SHORT INTEREST DECLINERS Ortex-reported short interest in Enliven Therapeutics (ELVN) had tracked in a 24%-29% range since mid-October but collapsed this week with a decline from 25.7% to 18.4% – a 14-month low. Days to cover on the stock also fell sharply from 7.8 to 6.9 in spite of a spike in volume last Friday – a 9-month low. The burst of trading activity, along with last Friday's 11% jump in the stock price that catalyzed the surge in short covering, was driven by the company's announcement of positive data from its Phase 1 clinical trial of ELVN-001 in patients with chronic myeloid leukemia. The results were then cheered by analysts at Goldman Sachs, who assigned a Buy rating to the stock with a price target of $37, implying another 50% return from current levels. In the four-day period covered, Enliven was up 9.7%, though shares are still down 5% year-to-date.

CNBC

an hour ago

• CNBC

Asia-Pacific markets set to open lower as U.S. bombing of Iran escalates Middle East crisis

Peter Adams | Stone | Getty Images Asia-Pacific markets are set to plunge Monday, after the United States' attack on three nuclear sites in Iran raised oil prices and investors' fears of an escalation in the Middle East conflict. Oil prices have spiked in recent weeks following the increased tensions in the Middle East. Brent Crude was trading at $78.88 per barrel after surging 2.48%, as of 7.30 a.m. Singapore time, while the West Texas Intermediate crude added 2.48% to $75.65. Japan's benchmark Nikkei 225 was set to open lower, with the futures contract in Chicago at 38,310, while its counterpart in Osaka last traded at 38,370, against the index's Friday close of 39,403.23. Futures for Hong Kong's Hang Seng index stood at 23,396, pointing to a weaker open compared to the HSI's last close of 23,530.48. Australia's S&P/ASX 200 is also slated to open lower, with futures tied to the benchmark at 8,469, compared to its last close of 8,505.50. U.S. equity futures fell in early Asia hours following the U.S. strikes in Iran. Futures tied to the Dow Jones Industrial Average fell by 109 points, or 0.3%. S&P 500 futures shed 0.3% and Nasdaq 100 futures lost 0.4%. Two of the three key benchmarks on Wall Street fell last Friday as investors kept watch on the Middle East conflict while contemplating the Federal Reserve's plans for interest rate cuts. The S&P 500 declined 0.22% to end at 5,967.84, making it the broad-based index's third consecutive losing session. The Nasdaq Composite dropped 0.51% and settled at 19,447.41, while the Dow Jones Industrial Average ticked up 35.16 points, or 0.08%, closing at 42,206.82. — CNBC's Lisa Kailan Han, Sean Conlon, Brian Evans contributed to this report.